Role of mitochondria, oxidative stress and the response to antioxidants in myalgic encephalomyelitis/chronic fatigue syndrome: A possible approach to SARS-CoV-2 ‘long-haulers’?
A significant number of SARS-CoV-2 (COVID-19) pandemic patients have developed chronic symptoms lasting weeks or months which are very similar to those described for myalgic encephalomyelitis/chronic fatigue syndrome. This study reviews the current literature and understanding of the role that mitoc...
Main Authors: | Emily Wood, Katherine H. Hall, Warren Tate |
---|---|
Format: | Article |
Language: | English |
Published: |
KeAi Communications Co., Ltd.
2021-03-01
|
Series: | Chronic Diseases and Translational Medicine |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2095882X20300839 |
Similar Items
-
Will COVID-19 Lead to Myalgic Encephalomyelitis/Chronic Fatigue Syndrome?
by: Anthony L. Komaroff, et al.
Published: (2021-01-01) -
A systematic review of nutraceutical interventions for mitochondrial dysfunctions in myalgic encephalomyelitis/chronic fatigue syndrome
by: Rebekah Maksoud, et al.
Published: (2021-02-01) -
Pathological Mechanisms Underlying Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
by: Daniel Missailidis, et al.
Published: (2019-07-01) -
A SWATH-MS analysis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome peripheral blood mononuclear cell proteomes reveals mitochondrial dysfunction
by: Eiren Sweetman, et al.
Published: (2020-09-01) -
Current Research Provides Insight into the Biological Basis and Diagnostic Potential for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
by: Eiren Sweetman, et al.
Published: (2019-07-01)